From: Analysis of 25 surgical cases of thymic neuroendocrine tumors and thymic carcinoma
TNET N = 9 | TC N = 16 | P-value | |
---|---|---|---|
Sex | |||
Male Female | 8(32) 1(4) | 8(32) 8(32) | 0.051 |
Age, years | |||
Mean/ Range | 60.0 / 45–83 | 61.6 / 39–82 | 0.737 |
Histology | LCNEC 3 (33) Ac 2 (22) SCC 2(22) *Other 2(22) | Sq 15 (93) AdSq 1 (7) | - |
Tumor size. mm | |||
Mean/ Range | 61.8 / 34–104 | 53 / 20–100 | 0.527 |
Masaoka stage | |||
I II III IV | 0(0) 3(33) 3(33) 3(33) | 1 (6) 4 (25) 7 (43) 4 (25) | 0.800 |
Preoperative therapy | |||
No Yes | 7(77) 2(22) | 14(87) 2 (12) | 0.527 |
Combined resection | |||
Yes No | 6(66) 3(33) | 13(81) 3(18) | 0.412 |
Lymph node metastases | |||
N0 N1, 2 | 8 (88) 1(11) | 13 (81) 3(18) | 0.617 |
Resection status | |||
R0 R1,2 | 8 (88) 1(11) | 13(81) 3(18) | 0.617 |
Postoperative therapy | |||
No Yes | 5 (55) 4(44) | 5(31) 11 (68) | 0.233 |
Recurrence | |||
No Yes | 4 (44) 5 (55) | 11 (68) 5 (31) | 0.233 |